SEC Form 4 · accession 0000899243-16-023041
CDW Corp · CDW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robin P Selati
Director
Period of report
Jun 15, 2016
Accepted (ET)
Jun 16, 2016 · 2:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001402057
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 | Jun 15, 2016 | J | 3,673 | $0.00 | A | 7,353 | D | |
| Common Stock, par value $0.01F3 | Jun 15, 2016 | J | 525 | $0.00 | A | 1,051 | I | By Robin P. Selati Dynasty Trust. See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On June 15, 2016: (a) Madison Dearborn Capital Partners V-A, L.P. ("MDP A") made a pro rata distribution for no consideration of 2,681,513 shares of common stock, par value $0.01, of CDW Corporation ("Shares"), to Madison Dearborn Partners V-A&C, L.P., its general partner ("MDP V"), and to its limited partners; (b) Madison Dearborn Capital Partners V-C, L.P. ("MDP C") made a pro rata distribution for no consideration of 711,359 Shares to MDP V, its general partner, and to its limited partners; (c) Madison Dearborn Capital Partners V Executive-A, L.P. ("MDP Exec") made a pro rata distribution for no consideration of 26,944 Shares to MDP V, its general partner, and to its limited partners; and (d) MDCP Co-Investor (CDW), L.P. ("MDP Co-Investor") made a pro rata distribution for no consideration of 688,100 Shares to its limited partners. MDP V further distributed on a pro rata basis for no consideration 88,056 Shares to its partners (the "MDP V Distribution").
- F2In the MDP V Distribution: (i) Mr. Selati received 3,673 Shares and (ii) the Robin P. Selati Dynasty Trust received 525 Shares.
- F3Mr. Selati's family members are the co-trustees of the Robin P. Selati Dynasty Trust. The indirect acquisition of such Shares by Mr. Selati was exempt under Rule 16a-9 and Rule 16a-13.